INTRODUCTION
Type 2 diabetes represents a major public health problem in China and its prevalence in Chinese adults is estimated to increase from 1.0% in 1980 to 5.5% in 2001, with no sign of slowing (1, 2) . Asian people including Chinese have been suggested to have a stronger genetic predisposition to type 2 diabetes because they are more centrally obese and pronounced dysfunction in early insulin secretion (1, 3, 4) . It is therefore likely that Asian population represents a good resource for identifying susceptibility genes of type 2 diabetes. However, almost all the type 2 diabetes-susceptibility loci have been identified in Europeans until recently.
KCNQ1 (potassium voltage-gated channel KQT-like subfamily, member 1) is a gene encoding the pore-forming subunit of a voltage-gated K þ channel (KvLQT1) that plays a key role for the repolarization of the cardiac action potential as well as water and salt transport in epithelial tissues (5 -7) . Both human and animal studies have suggested that mutations in KCNQ1 can lead to dysfunction of the channel and cause the cardiac long QT syndrome and congenital deafness (6 -10) . However, KCNQ1 is also expressed in pancreatic islets and the cultured insulin-secreting INS-1 cells (11, 12) , and blockade of the channel with KCNQ1 inhibitors 293B stimulated insulin secretion (12) , suggesting that KCNQ1 channels may play a role in regulation of insulin secretion. Recently, two independent genome-wide association studies (GWAS) in East Asian populations (13, 14) found that SNPs in a 40 kb block in intron 15 of KCNQ1 were consistently associated with type 2 diabetes and impairment of insulin secretion. The strongest associations with type 2 diabetes were observed for SNP rs2237892 and rs2237897 and each risk allele increased the odds of type 2 diabetes by 41 -49% in Japanese populations. The associations of these SNPs with type 2 diabetes were replicated in populations of Japanese, Korean, Chinese (Hong Kong and Singapore) and European ancestry. Furthermore, the nondiabetic individuals with CC genotype of SNP rs2237892 had significantly lower b-cell function as estimated by the homeostasis model assessment of b-cell function (HOMA-B) or corrected insulin response. Two subsequent studies replicated the association between KCNQ1 variants and type 2 diabetes in populations of Singapore Chinese (15) and Mainland Chinese from Shanghai (16) , respectively. These results suggest that KCNQ1 might play an important role in regulation of pancreatic b-cell insulin secretion and pathogenesis of type 2 diabetes, and the KCNQ1 variants are novel type 2 diabetes susceptibility loci. Therefore, it is important to validate the type 2 diabetes association of the KCNQ1 variants in more populations, particularly a general population, and to extend it to related intermediate traits to explore the potential mechanisms that underlie the association with type 2 diabetes. In the present study, we sought to validate the reported associations between the four common variants (rs2074196, rs2237892, rs2237895 and 2237897) in KCNQ1 and type 2 diabetes. We further explored the relationship of KCNQ1 polymorphisms with diabetes-related traits in a population-based cohort of Chinese Hans including 3210 unrelated individuals from Beijing and Shanghai.
RESULTS
The risk allele frequencies (64.5, 69.7, 33.2 and 66.6% for rs2074196, rs2237892, rs2237895 and rs2237897, respectively) observed in this study were similar to those observed for Hong Kong and Singapore Chinese as well as the CHB population of the HapMap, but much lower than those in HapMap CEU (96.7, 92.5, 45 and 94.5%, respectively). Analysis of pairwise linkage disequilibrium (LD) among the four SNPs showed that the LD is modest (0.05 r Fig. S1 ).
We first performed case -control studies to test for associations with type 2 diabetes and related phenotypes. The SNP rs2074196 showed a trend toward association with type 2 diabetes Table 1 ). The strongest association with type 2 diabetes was observed for SNP rs2237892 (OR: 1.36 [1.15 -1.62], P ¼ 0.0004) and its major (C) allele is the risk allele. Interestingly, rs2237892, rs2237895 and rs2237897 showed stronger associations with type 2 diabetes and weaker associations with IFG, whereas for rs2074196 the associations with type 2 diabetes and IFG were of a similar strength.
The corresponding population attributable risks (PAR) for type 2 diabetes in this Chinese population were estimated to be 35.8, 18.8 and 32.5% for SNPs rs2273892, rs2237895 and rs2273897, respectively. These results suggest that KCNQ1 is an important contributor to type 2 diabetes in the Chinese Hans. Yet, the area under receiver operating characteristics (ROC) curve (AUC) for SNPs rs2237892, rs2237895 and rs2237897 were 0.539, 0.542 and 0.534 (Table 2 ), respectively, suggesting that the predictive values of the KCNQ1 variants for genetic risk of type 2 diabetes are low. Moreover, combined with the previously identified six diabetes-associated genetic variants in this population resulted in an ROC AUC value of 0.599 and thus did not substantially improve the discriminative accuracy of type 2 diabetes prediction (Table 2) .
To identify potential mediators that link the KCNQ1 variants with type 2 diabetes, we tested the four SNPs for their associations with diabetes-related quantitative traits, including fasting glucose, HbA1C, fasting insulin, HOMA-B, HOMA-S and BMI (Table 3 ). The risk alleles of the four SNPs were all significantly associated with lower HOMA-B (P 0.0417). In addition, the risk alleles of SNPs rs2237895 and rs2237897 were also significantly associated with higher fasting glucose level (P 0.0115). To find out whether impaired beta cell function (estimated as decreased HOMA-B values) mediate the association between the four KCNQ1 variants and type 2 diabetes, we re-evaluated the association with type 2 diabetes with further adjustment for HOMA-B values ( (Table 1) . These observations led us to conduct Mendelian randomization analysis (triangulation approaches) by taking rs2237897 as an instrumental variable to test whether the impaired b-cell function was indeed a mediating factor in the association with type 2 diabetes (Fig. 1) . We found that the expected effect size, estimated by the magnitude of the association between KCNQ1 rs2237897 genotypes and HOMA-B values and of the association between the HOMA-B values and type 2 diabetes risk, was similar to the observed effect size of KCNQ1 rs2237897 genotypes on type 2 diabetes risk (P ¼ 0.70).
To further explore whether the associations for KCNQ1 variants were independent, we re-evaluated the association by including all four SNPs in one model. The results revealed that the associations were no longer significant (P ! 0.086) The ORs are odds ratios that represent the effects of risk alleles. All analyses were based on an additive model, in which individuals homozygous for the non-risk alleles were coded as 0, heterozygous individuals were coded as 1 and individuals homozygous for the risk alleles were coded as 2. (Table 1) . However, we did not observe significant association of the haplotypes carrying only one or two risk allele (GCAT, GTAT and TTAC) with type 2 diabetes or IFG (P ! 0.15).
In the quantitative trait analyses, both GCCC and GCAC haplotypes were significantly associated with lower HOMA-B values (P 0.047), while TCCC and GCAT haplotypes showed marginal association with HbA 1c (P 0.09) and fasting glucose (P ¼ 0.06 for TCCC) ( Table 3) . Consistent with the single SNP results, the associations of GCCC, TCCC and GCAC haplotypes with type 2 diabetes, IFG or combined IFG/type 2 diabetes were either abolished or markedly attenuated after adjusting for HOMA-B (Table 1) , further suggesting that impaired b-cell function was indeed a mediating factor in the association of common variants in KCNQ1 with type 2 diabetes.
DISCUSSION
In this population-based sample of Chinese Hans, we replicated the findings that common variants in KCNQ1 gene were significantly associated with type 2 diabetes and impaired insulin secretion. However, we observed different patterns of association with type 2 diabetes and IFG between rs2074196 and the other three SNPs. The SNPs rs2237892, rs2237895 and rs2237897 showed strong associations with type 2 diabetes, and weak but significant associations with IFG. In contrast, the SNP rs2074196 showed a significant association with IFG and a trend toward association with type 2 diabetes. Each copy of the risk alleles from rs2237892, rs2237895 or rs2237897 increase type 2 diabetes risks from 1.33-to 1.36-fold, similar to the original report in Japanese, Hong Kong Chinese (OR ¼ (14) , but very close to a recent report in Shanghai Chinese Hans (16) . The reason for this discrepancy is unknown.
The ORs of the two most strongly associated SNPs (rs2237892 and rs2237897, r 2 ¼ 0.61) observed in this study were higher than those observed for other known type 2 diabetes loci that we have reported previously for this population, except for CDKAL1 variants for which we observed higher ORs (OR: 1.49 [1.27 -1.75]) and for that of the CDKN2A/ B-rs10811661 for which we observed comparable effects (OR: 1.31 [1.12-1.54]) (17) . Because the risk allele frequencies of these two KCNQ1 variants are much higher than previously reported type 2 diabetes loci for the Chinese Hans (17), the corresponding PARs (32.5 -35.8%) for type 2 diabetes were even higher than those reported for TCF7L2 in individuals of European descent (18) . These results suggest that these KCNQ1 variants are likely more important contributors to type 2 diabetes susceptibility in the Chinese Hans than the previously reported loci. Yet, the low values of AUC suggest that the four SNPs have, on their own or together with another six diabetes-associated SNPs, little clinical predictive values for genetic risk of type 2 diabetes. We also confirmed the association of the KCNQ1 variants with impaired b-cell function estimated by HOMA-B, and the risk alleles of the four SNPs were all significantly associated with lower HOMA-B values. Importantly, the associations of the KCNQ1 variants with type 2 diabetes, IFG and combined IFG/type 2 diabetes were either abolished or dramatically attenuated after further adjustment for HOMA-B values. Additionally, the results of Mendelian randomization also suggest that the association between the HOMA-B values and type 2 diabetes risk is causal and unconfounded. Therefore, the KCNQ1 variants may be implicated in the pathogenesis of type 2 diabetes mainly through impaired insulin secretion of pancreatic b-cells although we cannot completely rule out the other possibilities. Consistent with this, the previous studies found that KCNQ1 gene is also expressed in pancreatic islets and KCNQ1 inhibitors 293B could stimulate insulin secretion by influencing action potential duration and frequency of the K þ channels (12) . However, no subjects with a mutation in KCNQ1 gene have been reported to show hyperglycemia or glucose intolerance. Kcnq1 knockout mice were characterized by cardiac dysfunction such as prolonged QT interval, hypochlorhydria, hypergastrinaemia, gastric hyperplasia and vacuolation of the parietal cells (9,10), but it remains to be confirmed whether a gain of function mutation in the KCNQ1 gene will contribute to impaired b-cell functions or type 2 diabetes. Therefore, the exact mechanisms by which the KCNQ1 variants confer type 2 diabetes risk remain elusive.
Further analysis revealed that, although three of the four variants were significantly associated with type 2 diabetes individually, the associations were no longer significant (P ! 0.086) after further adjusting for each other by including all the four SNPs in one model. Therefore, no evidence was found to suggest that any of the four SNPs individually is driving the type 2 diabetes association, but that the true causal variant responsible for the observed association between the single SNPs and type 2 diabetes when analyzed individually is likely in LD with the four SNPs.
In the haplotype-based association studies, the significance of associations between haplotypes and type 2 diabetes is comparable in magnitude with that observed with individual SNPs, but the major risk haplotypes (GCCC and TCCC) conferred a higher risk of type 2 diabetes than that attributed to the single SNPs in this population. However, the haplotypes bearing only one or two risk alleles did not show significant association with either type 2 diabetes or its related traits. The possible reason for this is that our population may have not enough power to detect the associations of these haplotypes with type 2 diabetes and its related traits due to their low frequency (,0.05) in this population.
Taken together, we confirmed that KCNQ1 is an important contributor to type 2 diabetes in the Chinese Hans, and the effect of KCNQ1 variants on type 2 diabetes is mainly mediated through impaired b-cell function.
MATERIALS AND METHODS

Study populations
The study sample consisted of 3210 individuals (1423 men, 1787 women) from the Study on Nutrition and Health of Aging Population in China. The study population, design and protocols of this population-based cohort study have been previously described in detail (17, 19) . Briefly, all participants were unrelated Chinese Hans, aged 50-70 years, with at least 20 years residence in Beijing or Shanghai. Among them, 424 participants had type 2 diabetes (267 had previously diagnosed type 2 diabetes and 157 had screen-detected and treatment-naïve type 2 diabetes), 878 participants had IFG (all 878 were screen-detected and treatment-naive) and 1908 participants had normal fasting glucose (NFG). Type 2 diabetes was defined by either 1999 World Health Organization criteria or previously diagnosed type 2 diabetes. The NFG and the IFG were defined as fasting glucose , 5.6 mmol/l (100 mg/dl) and 5.6 mmol/l (100 mg/dl) fasting glucose , 7.0 mmol/l (126 mg/dl), respectively. All participants attended a physical examination during which standard anthropometric measurements and overnight fasting blood samples were collected. Glucose was measured enzymatically on an automatic analyzer (Hitachi 7080, Japan) with reagents purchased from Wako Pure Chemical Industries (Osaka, Japan). Fasting insulin was determined by radioimmunoassay (Linco Research, MO, USA). HbA1c concentrations were measured by turbidometric immunoassay in RBC on the Hitachi 7080 Analyzer using reagents from Roche Diagnostics (Indianapolis, IN, USA). HOMA-S and HOMA-B, as measures of insulin sensitivity and b-cell function respectively, were estimated by the homeostasis model using Levy's computer model (20) . Written informed consent was obtained from all participants and study protocols were approved by the Institute Review Board of Institute for Nutritional Sciences. The phenotypic characteristics of the population are shown in Table 4 .
Genotyping
Five common variants in a 40 kb LD block of KCNQ1 intron 15 have been reported to be associated with type 2 diabetes in two recent GWAS in East Asian populations. Only SNPs rs2074196, rs2237892, rs2237895 and rs2237897 were genotyped in our population and examined their associations with type 2 diabetes and IFG, a fifth SNP (rs2283228) failed at the assay design stage. Genomic DNA was extracted from peripheral blood leukocytes by salting out procedure (http:// www.protocol-online.org/prot/Detailed/3171.html). SNP genotyping was performed with TaqMan SNP allelic discrimination by the ABI PRISM 7900HT Sequence Detection System (Applied Biosystems) according to the manufacturer's protocol. The genotyping success rates of SNPs rs2074196, rs2237892, rs2237895 and rs2237897 were 98.7, 98.4, 99.0 and 99.0%, respectively, and the concordance rates were both more than Figure 1 . Results of Mendelian randomization analyses. b1, the effect size of association between SNP rs2237897 and HOMA-B values; b2, the effect size of association between HOMA-B values and type 2 diabetes; b3 (obs) , the observed effect size of association between SNP rs2237897 and type 2 diabetes; b3 (exp) , the expected effect size of association between SNP rs2237897 and type 2 diabetes, calculated by multiplying the magnitudes of rs2237897-HOMA-B and HOMA-B-type 2 diabetes (b3 ¼ b1 Â b2); P (obs/exp) , P-value for difference between b3 (obs) and b3 (exp) .
99% based on 12% duplicate samples (n ¼ 384). The allele frequencies and LD (Supplementary Material, Fig. S1 ) of these four SNPs were comparable with those in the HapMap HCB database or previously reported Chinese individuals in Hong Kong, Singapore and Shanghai, and all in Hardy -Weinberg equilibrium (HWE) (P . 0.06). The genotype distributions of both SNPs were similar in men and women (P . 0.10) and between Beijing and Shanghai (P . 0.20).
Statistical analysis
Hardy -Weinberg equilibrium was tested using a likelihood ratio test. The ORs and 95% CIs were estimated by logistic regression under an additive model, adjusting for sex, age, geographical region (Shanghai versus Beijing) and BMI, to determine the association between each SNP and type 2 diabetes and IFG. Generalized linear regression was applied to quantitative traits analysis in which participants with known diabetes or receiving glucose-lowering treatment (n ¼ 267) were excluded, adjusting for age, sex, geographical region (Shanghai/Beijing) and BMI (where appropriate) under an additive model. Insulin and HOMA-S were natural logtransformed before analyses and the data were presented as geometric means. LD estimation was performed by Haploview V3.2 (http://www.broad.mit.edu/mpg/haploview). The predictive values of each SNPs for genetic risk of type 2 diabetes was assessed by the AUC under a logistic regression model. Haplotypic analysis was assessed using SimHap version 1.0.0 (http://www.genepi.org.au/simhap.html) based on the packages in R software (http://www.r-project.org). The potential causal relationship between HOMA-B values and type 2 diabetes was explored by using Mendelian randomization (triangulation approach). The assumptions underlying the triangulation approach is that genetic variants in the KCNQ1 gene are randomly transmitted to the offspring and largely free from reverse causation and confounding. If the association between low HOMA-B values and type 2 diabetes is causal, then the genetic variants associated with HOMA-B should also be associated with risk of type 2 diabetes for the individuals carrying these variants to the extent predicted by the magnitudes of the associations between genetic variant and HOMA-B and between HOMA-B and type 2 diabetes. Otherwise, the causality is refuted. Therefore, we applied a stepwise approach including the following analyses: (i) observed effect between HOMA-B and type 2 diabetes risk; (ii) observed effect between KCNQ1 gene and HOMA-B values; (iii) observed effect between KCNQ1 gene and type 2 diabetes risk and (iv) expected effect between KCNQ1 gene and type 2 diabetes risk. The expected effect size of KCNQ1 gene and type 2 diabetes risk association was calculated by multiplying the magnitudes of observed effects between HOMA-B and type 2 diabetes risk, and observed effect between KCNQ1 gene and HOMA-B values. The associations were estimated using logistic regression or generalized linear regression as described above. All reported P-values are nominal and two-sided. Association analyses and ROC AUC calculation were performed with SAS (version 9.1, SAS Institute, Cary, NC, USA).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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